Regulation of glutamatergic signalling by PACAP in the mammalian suprachiasmatic nucleus

BMC Neuroscience

Volumn 7, Issue , 2006, Pages

  Michel, Stephan ^a   Itri, Jason ^b   Han, Jung H ^b   Gniotczynski, Kathryn ^b   Colwell, Christopher S ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CALCIUM ION; GLUTAMIC ACID; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; AMINO ACID RECEPTOR STIMULATING AGENT; CALCIUM; ENZYME INHIBITOR; ISOQUINOLINE DERIVATIVE; N (2 (4 BROMOCINNAMYLAMINO)ETHYL) 5 ISOQUINOLINESULFONAMIDE; N METHYLASPARTIC ACID; N-(2-(4-BROMOCINNAMYLAMINO)ETHYL)-5-ISOQUINOLINESULFONAMIDE; SULFONAMIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL POPULATION; CONTROLLED STUDY; EVOKED RESPONSE; EXCITATORY POSTSYNAPTIC POTENTIAL; MOLECULAR MECHANICS; MOUSE; NERVE CELL MEMBRANE POTENTIAL; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; REGULATORY MECHANISM; RETINA GANGLION CELL; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SUPRACHIASMATIC NUCLEUS; SYNAPTIC TRANSMISSION; ANIMAL; COMPARATIVE STUDY; CYTOLOGY; DIAGNOSTIC IMAGING; DRUG EFFECT; DRUG INTERACTION; ELECTROSTIMULATION; IN VITRO STUDY; METABOLISM; METHODOLOGY; NERVE CELL; PATCH CLAMP; PHYSIOLOGY; RADIATION EXPOSURE; RAT; VIDEO MICROSCOPY;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; CALCIUM; DIAGNOSTIC IMAGING; DRUG INTERACTIONS; ELECTRIC STIMULATION; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; ISOQUINOLINES; MICE; MICROSCOPY, VIDEO; N-METHYLASPARTATE; NEURONS; NEUROTRANSMITTER AGENTS; PATCH-CLAMP TECHNIQUES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; SIGNAL TRANSDUCTION; SULFONAMIDES; SUPRACHIASMATIC NUCLEUS;

EID: 33644772271     PISSN: 14712202     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-7-15     Document Type: Article

References (53)

1. Berson DM, Dunn FA, Takao M: Phototransduction by retinal gan glion cells that set the circadian clock. Science 2002, 295(5557):1070-1073.
2. Hattar S, Liao HW, Takao M, Berson DM, Yau KW: Melanopsincontaining retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science 2002, 295(5557):1065-1070.
3. Ebling FJ: The role of glutamate in the photic regulation of the suprachiasmatic nucleus. Prog Neurobiol 1996, 50(2-3):109-132.
4. Colwell CS, Menaker M: Regulation of circadian rhytms by excitatory amino acids. In Excitatory Amino Acids.. Their Role in Neuroendocrine Function CRC Press; 1996:223-252.
5. Colwell CS: Circadian modulation of calcium levels in cells in the suprachiasmatic nucleus. Eur J Neurosci 2000, 12(2):571-576.
6. Ikeda M, Sugiyama T, Wallace CS, Gompf HS, Yoshioka T, Miya waki A, Alien CN: Circadian dynamics of cytosolic and nuclear Ca2+ in single suprachiasmatic nucleus neurons. Neuron 2003, 38(2):253-263.
7. Ding JM, Chen D, Weber ET, Faiman LE, Rea MA, Gillette MU: Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO. Science 1994, 266(5191):1713-1717.
8. Obrietan K, Impey S, Storm DR. Light and circadian rhythmicity regulate MAP kinase activation in the suprachiasmatic nuclei. Nat Neurosci 1998, 1(8):693-700.
9. Reppert SM, Weaver DR: Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 2001, 63:647-676.
10. Hannibal J, Moller M, Ottersen OP, Fahrenkrug J: PACAP and glutamate are co-stored in the retinohypothalamic tract. J Camp Neural 2000, 418(2):147-155.
11. Hannibal J, Hindersson P, Knudsen SM, Georg B, Fahrenkrug J: The photopigment melanopsin is exclusively present in pituitary adenylate cyclase -activating polypeptide -containing retinal ganglion cells of the retinohypothalamic tract. J Neurosci 2002, 22(1):RC 191.
12. Cagampang FR, Piggens HD, Sheward WJ, Harmar AJ, Coen CW: Circadian changes in PACAP type 1 (PAC1) receptor mRNA in the rat suprachiasmatic and supraoptic nuclei. Brain Res 1998, 813(1):218-222.
13. Cagampang FR, Sheward WJ, Harmar AJ, Piggins HD, Coen CW: Circadian changes in the expression of vasoactive intestinal peptide 2 receptor mRNA in the rat suprachiasmatic nuclei. Brain Res Mol Brain Res 1998, 54(1):108-112.
14. Shinohara. K, Funabashi T, Kimura F: Temporal profiles of vasoactive intestinal polypeptide precursor mRNA and its receptor mRNA in the rat suprachiasmatic nucleus. Brain Res Mol Brain Res 1999, 63(2):262-267.
15. Kalamatianos T. Kallo I, Piggins HD, Coen CW: Expression of VIP and/or PACAP receptor mRNA in peptide synthesizing cells within the suprachiasmatic nucleus of the rat and in its efferent target sites. J Comp Neurol 2004, 475(1):19-35.
16. Kopp MD, Schomerus C, Dehghani F, Korf HW, Meissl H: Pituitary adenylate cyclase-activating polypeptide and melatonin in the suprachiasmatic nucleus: effects on the calcium signal transduction cascade. J Neurosci 1999, 19(1):206-219.
17. Dziema H, Obrietan K: PACAP potentiates L -type calcium channel conductance in suprachiasmatic nucleus neurons by activating the MAPK pathway. J Neurophysiol 2002, 88(3):1374-1386.
18. Butcher GQ, Lee B, Cheng HY, Obrietan K: Light stimulates MSKI activation in the suprachiasmatic nucleus via a PACAP-ERK/MAP kinase-dependent mechanism. J Neurosci 2005, 25(22)5305-5313.
19. Nielsen HS, Hannibal J. Knudsen SM, Fahrenkrug J: Pituitary adenylate cyclase -activating polypeptide induces period 1 and period2 gene expression in the rat suprachiasmatic nucleus during late night. Neuroscience 2001, 103(2).433-441.
20. Nielsen HS, Georg B, Hannibal J, Fahrenkrug J: Homer-1 mRNA in the rat suprachiasmatic nucleus is regulated differentially by the retinohypothalamic tract transmitters pituitary adenylate cyclase activating polypeptide and glutamate at time points where light phase-shifts the endogenous rhythm. Brain Res Mol grain Res 2002, 105(1-2):79-85.
21. Fahrenkrug J, Hannibal J, Honore B, Vorum H: Altered calmodulin response to light in the suprachiasmatic nucleus'of PAC 1 receptor knockout mice revealed by proteomic analysis. J Mol Neurosci 2005, 25(3):251-258.
22. Hannibal J, Ding JM, Chen D, Fahrenkrug J, Larsen PJ, Gillette MU, Mikkelsen JD: Pituitary adenylate cyclase-activating peptide (PACAP) in the retinohypothalamic tract: a potential daytime regulator of the biological clock. J Neurosci 1997, 17(7):2637-2644.
23. Harrington MF, Hoque S, Hall A, Golombek D, Biello S: Pituitary adenylate cyclase activating peptide phase shifts circadian rhythms in a manner similar to light. J Neurosci 1999, 19(15):6637-6642.
24. Chen D, Buchanan GF, Ding JM, Hannibal J, Gillette MU: Pituitary adenylyl cyclase-activating peptide: a pivotal modulator of glutamatergic regulation of the suprachiasmatic circadian clock. Proc Natl Acad Sci USA 1999, 96(23):13468-13473.
25. Piggins HD, Marchant EG, Goguen D, Rusak B: Phase-shifting effects of pituitary adenylate cyclase activating polypeptide on hamster wheel-running rhythms. Neurosci Lett 2001, 305(1):25-28.
26. Minami Y, Furuno K. Akiyama M, Moriya T, Shibata S: Pituitary adenylate cyclase-activating polypeptide produces a phase shift associated with induction of mPer expression in the mouse suprachiasmatic nucleus. Neuroscience 2002, 113(1)37-45.
27. Bergstrom AL, Hannibal J, Hindersson P, Fahrenkrug J: Lightinduced phase shift in the Syrian hamster (Mesocricetus auratus) is attenuated by the PACAP receptor antagonist PACAP6-38 or PACAP immunoneutralization. Eur J Neurosci 2003, 18(9):2552-2562.
28. Hannibal J, Jamen F, Nielsen HS, Journot L. Brabet P, Fahrenkrug J: Dissociation between light-induced phase shift of the circadia rhythm and clock gene expression in mice lacking the pituitary adenylate cyclase activating polypeptide type 1 receptor. J Neurosci 2001, 21(13):4883-4890.
29. Harmar AJ, Marston HM, Shen S, Spratt C, West KM, Sheward WJ, Morrison CF, Dorin JR, Piggins HD, Reubi JC, Kelly JS, Maywood ES, Hastings MH.: The VPAC(2) receptor is essential for circadian function in the mouse suprachiasmatic nuclei. Cell 2002, 109(4):497-508.
30. Kawaguchi C, Tanaka K, Isojima Y, Shintani N, Hashimoto H, Baba A, Nagai K. Changes in light-induced phase shift of circadian rhythm in mice lacking PACAP. Biochem Biophys Res Commun 2003, 310(1):169-175.
31. Colwell CS, Michel S, Itri J, Rodriguez W, Tam J, Lelievre V, Hu Z, Waschek JA. Selective deficits in the circadian light response in mice lacking PACAP. Am J Physiol Regul Integr Comp Physiol 2004, 287(5):R1194-1201.
32. Colwell CS. NMDA-evoked calcium transients and currents in the suprachiasmatic nucleus: gating by the circadian system. Eur J Neurosci 2001, 13(7): 1420-1428.
33. Michel S, Itri J, Colwell CS: Excitatory mechanisms in the suprachiasmatic nucleus: the role of AMPA/KA glutamate receptors. J Neurophysiol 2002, 88(2):817-828.
34. Kopp MD, Meissl H, Dehghani F, Korf HW: The pituitary adenylate cyclase -activating polypeptide modulates glutamatergic calcium signalling. investigations on rat suprachiasmatic nucleus neurons. J Neurochem 2001, 79(1):161-171.
35. Seki T, Shioda S, Ogino D, Nakai Y, Arimura A, Koide R. Distribution and ultrastructural localization of a receptor for pituitary adenylate cyclase activating polypeptide and its mRNA in the rat retina. Neurosci Lett 1997, 238(3):127-130.
36. Roberto M, Brunelli M: PACAP-38 enhances excitatory synaptic transmission in the rat hippocampal CAI region. Learn Mem 2000, 7(5):303-311.
37. Gillette MU: The suprachiasmatic nuclei: circadian phaseshifts induced at the time of hypothalamic slice preparation are preserved in vitro. Brain Res 1986, 79(1):176-181.
38. Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H: Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacal Rev 2000, 52(2):269-324.
39. Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR, Robberecht P, Said SI, Sreedharan SP, Wank SA, Waschek JA. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmocol Rev 1998, 50(2):265-270.
40. Moro O, Lerner EA: Maxadilan, the vasodilator from sand flies, is a specific pituitary adenylate cyclase activating peptide type 1 receptor agonist. J Biol Chem 1997, 272(2).966-970.
41. Uchida D; Tatsuno I, Tanaka T, Hirai A, Saito Y. Moro, O, Tajima M: Maxadilan is a specific agonist and its deleted peptide (M65) is a specific antagonist for PACAP type 1 receptor. Ann N Y Acad Sci 1998, 865:253-258.
42. Moro O, Wakita K, Ohnuma M, Denda S, Lerner EA, Tajima M: Functional characterization of structural alterations in the sequence of the vasodilatory peptide maxadilan yields a pituitary adenylate cyclase-activating peptide type 1 receptor-specific antagonist. J Biol Chem 1999, 274(33):23103-23110.
43. Eggenberger M, Born W, Zimmermann U, Lerner EA, Fischer JA, Muff R: Maxadilan interacts with receptors for pituitary adenylyl cyclase activating peptide in human SH-SY5Y and SK-N-MC neuroblastorna cells. Neuropeptides 1999, 33(2):107-114.
44. Reed HE, Cutler DJ, Brown TM, Brown J, Coen CW, Piggins HD: Effects of vasoactive intestinal polypeptide on neurones of the rat suprachiasmatic nuclei in vitro. J Neuroendocrinol 2002, 14(8):639-646.
45. von Gall C, Duffield GE, Hastings MH, Kopp MD, Dehghani F, Korf HW, Stehle JH: CREB in the mouse SCN: a molecular interface coding the phase -adjusting stimuli light, glutamate, PACAP, and melatonin for clockwork access. J Neurosci 1998, 18(24):10389-10397.
46. Spengler D, Waeber C Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, Journot L: Differential signal transduction by five splice variants of the PACAP receptor. Nature 1993, 365:170-175.
47. Ajpru S, McArthur AJ, Piggins HD, Sugden D: Identification of PAC1 receptor isoform mRNAs by real-time PCR in rat suprachiasmatic nucleus. Brain Res Mol Brain Res 2002, 105(12):29-37.
48. Dingledine R, Borges K. Bowie D, Traynelis SF: The glutamate receptor ion channels. Pharmacol Rev 1999, 51:7-61.
49. McBain CJ, Mayer ML. N-methyl-D-aspartic acid receptor structure and function. Physiol Rev 1994, 74:723-60.
50. Yaka K He DY, Phamluong K, Ron D: Pituitary adenylate cyclase-activating polypeptide (PACAP(1-38)) enhances N -methyl-D-aspartate receptor function and brain-derived neurotrophic factor expression via RACKI. J Biol Chem 2003, 278(11):9630-8.
51. Gillette MU, Mitchell JW. Signaling in the suprachiasmatic nucleus: selectively responsive and integrative. Cell Tissue Res 2002,309(1):99-107.
52. Moriya T, Ikeda M, Teshima K, Hara R, Kuriyama. K, Yoshioka T, Allen CN, Shibata S: Facilitation of alpha-amino-3-hydroxy-5-methylisoxazole -4-propionate receptor transmission in the suprachiasmatic nucleus by aniracetam enhances photic responses of the biological clock in rodents. J Neurochem 2003, 85(4):978-987.
53. Itri J, Colwell CS: Regulation of inhibitory synaptic transmission by vasoactive intestinal peptide (VIP) in the mouse suprachiasmatic nucleus. J Neurophysiol 2003, 90(3):1589-1597.